docetaxel anhydrous has been researched along with alendronate in 5 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (alendronate) | Trials (alendronate) | Recent Studies (post-2010) (alendronate) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 4,096 | 731 | 1,724 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | alendronate (IC50) |
|---|---|---|---|
| Chain A, farnesyl pyrophosphate synthase | Trypanosoma cruzi | 147 | |
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | 0.7523 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kokawa, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G | 1 |
| Bronich, TK; Cohen, SM; Hyun, MA; Liu, T; Romanova, S; Singh, RK; Wang, S; Zhang, C | 1 |
| Bai, SB; Cheng, Y; Ji, QF; Liu, DZ; Liu, M; Mei, QB; Zhang, BL; Zhou, SY | 1 |
| Guo, P; Lun Wong, H; Wen, W; Xue, HY | 1 |
1 review(s) available for docetaxel anhydrous and alendronate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for docetaxel anhydrous and alendronate
| Article | Year |
|---|---|
[Effective alendronate therapy against a bone metastasis occurring during docetaxel therapy for breast cancer--a case report].
Topics: Aged; Alendronate; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Docetaxel; Female; Humans; Neoplasm Recurrence, Local; Paclitaxel; Taxoids | 1999 |
Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Liberation; Female; Mice; Mice, Inbred BALB C; Micelles; Polymers; RAW 264.7 Cells; Transplantation, Homologous; Treatment Outcome | 2019 |
Bone-targeted PAMAM nanoparticle to treat bone metastases of lung cancer.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Docetaxel; Drug Delivery Systems; Lung Neoplasms; Mice; Nanoparticles; Polyamines | 2020 |
Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasis.
Topics: Alendronate; Bone Neoplasms; Diterpenes; Docetaxel; Epoxy Compounds; Humans; Phenanthrenes | 2022 |